PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

The Good Doctor - Part 3, page-5

  1. 4,356 Posts.
    lightbulb Created with Sketch. 6904
    Whitta- thanks! Love researching and writing about us, I’ve never done so much research about any investment like this!

    Erie2011-A book by the Mozz haha good one!
    it would be easy to write one, lots of material.
    when I first saw that MOA piece from Par I was amazed, I read it that day about 5 times. But I never thought that it would propel the stock, I thought it was too sciency and the investment community wouldn’t value it like you and me. (And most par hc’ers).

    I agree with you, it’s undervalued and no third party research houses tend to cover it. It is this concept that will propel us as that is the reason it works, that’s the mechanics and nothing else has followed this action before. Paul also mentioned this NGF concept and how it is the gold that big pharma is looking for, we are going to get a lot of attention. If huge pharma like Pfizer spent millions on NGF treatments and have failed, imagine the future interest as more of our raw data comes to light- It will be looked at further as we progress. Brilliant.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.